首页> 外文期刊>International Journal of Medical Sciences >A Paired-Comparision of the MultiFunction CardioGramsm (MCG) and Sestamibi SPECT Myocardial Perfusion Imaging (MPI) to Quantitative Coronary Angiography for the Detection of Relevant Coronary Artery Obstruction (≥70%) - A Single-Center Study of 116 Consecutive Patients Referred for Coronary Angiography
【24h】

A Paired-Comparision of the MultiFunction CardioGramsm (MCG) and Sestamibi SPECT Myocardial Perfusion Imaging (MPI) to Quantitative Coronary Angiography for the Detection of Relevant Coronary Artery Obstruction (≥70%) - A Single-Center Study of 116 Consecutive Patients Referred for Coronary Angiography

机译:多功能心电图(MCG)和Sestamibi SPECT心肌灌注显像(MPI)与定量冠状动脉造影的配对比较,以检测相关的冠状动脉梗阻(≥70%)-对116例连续转诊冠心病患者进行单中心研究血管造影

获取原文
           

摘要

Background: An analysis of the US National Cardiovascular Data Registry has revealed that only 38% of patients referred for coronary angiography after non-invasive coronary testing have relevant coronary obstruction (CO) (≥70%) of one or more coronary arteries. Methods: A single-center trial was undertaken in 165 consecutive, symptomatic patients with either known or suspected coronary disease and/or valve disease(VHD) who agreed to undergo cardiac catheterization and coronary angiography if stress myocardial perfusion imaging was abnormal. A total of 116 patients with abnormal SPECT MPI tests, persistent chest pain, or significant VHD underwent final analysis. An MCG coronary obstruction (CO) score of ≥ 4.0 was considered indicative of relevant CO (≥70%) in one or more coronary arteries. Angiographic results were finalized by consensus of two angiographers. Results: CO (≥70%) was present in 53 of 116 patients (46%). The MCG CO score was significantly higher for patients with relevant CO (5.4 ± 1.9 vs. 2.5 ± 1.9). The MCG correctly classified 103 of the 116 patients (89%) enrolled in the study as either having or not having CO (≥70%) (sensitivity- 91%; specificity- 87%; NPV- 92%; PPV- 86%). SPECT MPI was abnormal in 99 of the 116 (85%) patients undergoing catheterization, but correctly classified only 54 of the 116 patients (47%) entered in the study as either having or not having relevant CO (sensitivity-85%; specificity-14%; NPV - 53%; PPV- 45%). Conclusions: The MCG was shown in this paired-comparison trial with SPECT MPI to safely and accurately identify patients with relevant CO (≥70%) prior to catheterization.
机译:背景:对美国国家心血管数据注册中心的分析显示,在非侵入性冠状动脉检查后转诊进行冠状动脉造影的患者中,只有38%的患者具有一个或多个冠状动脉的相关冠状动脉阻塞(CO)(≥70%)。方法:对165名连续的有症状或已知或疑似冠心病和/或瓣膜病(VHD)的症状患者进行了单中心试验,这些患者同意在压力心肌灌注显像异常时接受心脏导管检查和冠状动脉造影。共有116例SPECT MPI测试异常,持续性胸痛或明显VHD的患者接受了最终分析。 ≥4.0的MCG冠状动脉阻塞(CO)分数被认为指示一个或多个冠状动脉中的相关CO(≥70%)。血管造影结果由两名血管造影师共同确定。结果:116名患者中有53名(46%)存在CO(≥70%)。相关CO患者的MCG CO评分显着更高(5.4±1.9 vs. 2.5±1.9)。 MCG将参与研究的116名患者中的103名(89%)正确分类为是否患有CO(≥70%)(敏感性-91%;特异性-87%; NPV- 92%; PPV- 86%) 。 SPECT MPI在116名(85%)接受导管插入的患者中有99名异常,但是正确地将116名患者(54%)中的54名分类为有或没有相关的CO(敏感性为85%;特异性为- 14%; NPV-53%; PPV- 45%)。结论:在这项配对比较试验中,MCG与SPECT MPI一起显示,可以在导管插入之前安全,准确地识别出相关CO(≥70%)的患者。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号